Literature DB >> 10687867

CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory.

G Wake1, J Court, A Pickering, R Lewis, R Wilkins, E Perry.   

Abstract

Certain Lamiaceous and Asteraceous plants have long histories of use as restoratives of lost or declining cognitive functions in western European systems of traditional medicine. Investigations were carried out to evaluate human CNS cholinergic receptor binding activity in extracts of those European medicinal plants reputed to enhance or restore mental functions including memory. Ethanolic extracts were prepared from accessions of these plants and a number of other species related by genus. Amongst the plant extracts screened for contents able to displace [3H]-(N)-nicotine and [3H]-(N)-scopolamine from nicotinic receptors and muscarinic receptors, respectively in homogenates of human cerebral cortical cell membranes, the most potent extracts, prepared from one accession of Melissa officinalis, three Salvia species and Artemisia absinthium had IC50 concentrations of < 1 mg/ml. The displacement curves of some extracts were comparable with that of carbamylcholine chloride, a potent acetylcholine analogue. Choline, a weak nicotinic ligand (IC50 = 3 x 10(-4) M) was found in extracts of all plants studied at concentrations of 10(-6)-10(-5) M. These concentrations could not account for not more than 5% of the displacement activity observed. Some extracts displayed differential displacement at nicotinic and muscarinic acetylcholine receptors, with M. officinalis 0033 having the highest [3H]-(N)-nicotine displacement value and Salvia elegans with the highest [3H]-(N)-scopolamine displacement value. There was also considerable variation in cholinoreceptor interactions between different accessions of a single plant species. Although most plant extracts screened showed some nicotinic and muscarinic activity, only some showed dose-dependent receptor activity typical of materials with genuine cholinergic activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10687867     DOI: 10.1016/s0378-8741(99)00113-0

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  28 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Assault on the thyroid by xenobiotics: another attack on G-protein coupled.

Authors:  S Benvenga
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

Review 3.  Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.

Authors:  Nicolette Perry; Elaine Perry
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma.

Authors:  Mark Moss; Lorraine Oliver
Journal:  Ther Adv Psychopharmacol       Date:  2012-06

Review 5.  Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function.

Authors:  David O Kennedy; Emma L Wightman
Journal:  Adv Nutr       Date:  2011-01-10       Impact factor: 8.701

6.  Comparison of Neuroprotective Effects of Melissa officinalis Total Extract and Its Acidic and Non-Acidic Fractions against A β-Induced Toxicity.

Authors:  Mohammad Reza Sepand; Maliheh Soodi; Homa Hajimehdipoor; Masoud Soleimani; Ehsan Sahraei
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

7.  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Authors:  Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh Togha; Hamed Cheraghmakani; Soodeh Razeghi; Seyyed Shamssedin Hejazi; Mohammad Hossein Yousefi; Roozbeh Alimardani; Amirhossein Jamshidi; Shams-Ali Rezazadeh; Aboulghasem Yousefi; Farhad Zare; Atbin Moradi; Ardalan Vossoughi
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

8.  Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial.

Authors:  S Akhondzadeh; M Noroozian; M Mohammadi; S Ohadinia; A H Jamshidi; M Khani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

9.  Comparison of some antioxidant properties of plant extracts from Origanum vulgare, Salvia officinalis, Eleutherococcus senticosus and Stevia rebaudiana.

Authors:  Ladislav Vaško; Janka Vašková; Andrea Fejerčáková; Gabriela Mojžišová; Janka Poráčová
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-04-16       Impact factor: 2.416

Review 10.  Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing.

Authors:  Melanie-Jayne R Howes; Nicolette S L Perry; Carlos Vásquez-Londoño; Elaine K Perry
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.